On November 25, 2024, the Stochastic Oscillator for CHTM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 14 instances where the indicator left the oversold zone. In of the 14 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The Moving Average Convergence Divergence (MACD) for CHTM just turned positive on November 25, 2024. Looking at past instances where CHTM's MACD turned positive, the stock continued to rise in of 16 cases over the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (3.309). CHTM has a moderately low P/E Ratio (0.000) as compared to the industry average of (26.397). CHTM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.706). Dividend Yield (0.033) settles around the average of (0.103) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (305.264).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CHTM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHTM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
Industry MetalFabrication
A.I.dvisor tells us that CHTM and MTRT have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHTM and MTRT's prices will move in lockstep.
Ticker / NAME | Correlation To CHTM | 1D Price Change % | ||
---|---|---|---|---|
CHTM | 100% | N/A | ||
MTRT - CHTM | 3% Poorly correlated | -34.46% | ||
GFLT - CHTM | -0% Poorly correlated | +4.07% | ||
BEKAY - CHTM | -0% Poorly correlated | N/A | ||
ESAB - CHTM | -1% Poorly correlated | -4.35% | ||
RMTO - CHTM | -1% Poorly correlated | -7.18% | ||
More |
Ticker / NAME | Correlation To CHTM | 1D Price Change % |
---|---|---|
CHTM | 100% | N/A |
Metal Fabrication industry (35 stocks) | 47% Loosely correlated | -2.38% |